Related Experiment Video
Updated: Jan 28, 2026

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Airway microbiota in patients with paediatric cystic fibrosis: Relationship with clinical status
Antonia Sánchez-Bautista1, Juan Carlos Rodríguez-Díaz1, Inmaculada Garcia-Heredia1
1Department of Microbiology, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Insights
Children with cystic fibrosis (CF) and lower airway microbiome biodiversity, particularly higher Staphylococcus aureus levels, showed increased lung damage. Greater microbial diversity may indicate slower disease progression.
Area of Science:
- Microbiology
- Pediatric Pulmonology
- Genetics
Background:
- Massive sequencing enables airway microbiota analysis in cystic fibrosis (CF) patients.
- The link between lung microbiome composition and pediatric CF clinical status requires further investigation.
Purpose of the Study:
- To investigate the association between airway microbiome composition and clinical status in pediatric CF patients.
- To explore the relationship between lung microbiome diversity and disease severity in children with CF.
Main Methods:
- Cross-sectional observational study on induced sputum samples from children with CF.
- Bacterial 16S rRNA gene sequencing and analysis of associations with clinical variables.
Main Results:
- A core microbiome included Staphylococcus, Streptococcus, Rothia, Gemella, and Granulicatella species.
- Lower microbiome biodiversity correlated with increased Staphylococcus spp., notably Staphylococcus aureus (p=0.009).
- Reduced microbial diversity was associated with greater lung damage in pediatric CF patients.
Conclusions:
- Airway microbiome biodiversity may serve as an indicator of CF disease progression.
- Therapeutic strategies targeting the preservation of non-pathogenic airway microbiota warrant investigation.
Introduction:
New massive sequencing techniques make it possible to determine the composition of airway microbiota in patients with cystic fibrosis (CF). However, the relationship between the composition of lung microbiome and the clinical status of paediatric patients is still not fully understood.
Material And Methods:
A cross-sectional observational study was conducted on induced sputum samples from children with CF and known mutation in the CFTR gene. The bacterial sequences of the 16SrRNA gene were analyzed and their association with various clinical variables studied.
Results:
Analysis of the 13 samples obtained showed a core microbiome made up of Staphylococcus spp., Streptococcus spp., Rothia spp., Gemella spp. and Granulicatella spp., with a small number of Pseudomonas spp. The cluster of patients with less biodiversity were found to exhibit a greater number of sequences of Staphylococcus spp., mainly Staphylococcus aureus (p 0.009) and a greater degree of lung damage.
Conclusion:
An airway microbiome with greater biodiversity may be an indicator of less pronounced disease progression, in which case new therapeutic interventions that prevent reduction in non-pathogenic species of the airway microbiota should be studied.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Relationship Formation
Ending Relationships
Relationship Growth
Marcia's Theory of Identity Status

